Psychedelic Stocks and News
RSS Error: A feed could not be found at `https://psychedelicspotlight.com/psychedelic-news/`; the status code is `200` and content-type is `text/html; charset=UTF-8`
Scholars for the first time identified chemical signatures of the components of a liquid concoction contained in a Bes mug. A new technique helped identify a sample flavored with honey,… Read More
New research suggests that it could be possible to separate treatment from hallucinations when developing new drugs based on psychedelics. The anti-anxiety andhallucination-inducing qualities of psychedelic drugs work through different… Read More
A classic psychedelic, similar to LSD, psilocybin and mescalin, was found to activate a cell type in the brain that silences other neighboring neurons, a result that provides insight into… Read More
Feeling safe and comfortable are key when discussing your health and wellbeing with your primary care provider. However, that feeling of comfort and safety can't be taken for granted among… Read More
A new tool to track the neurons and molecules activated in the brain by psychedlic drugs could help scientists unlock the benefits of psychedelic treatments for patients with brain disorders. Read More
Researchers report that psilocybin, the active ingredient in magic mushrooms, destabilizes a critical network of brain areas involved in introspective thinking. The findings provide a neurobiological explanation for the drug's… Read More
A clinic in Montreal received Health Canada's approval on May 5 to care for a patient who had undergone several unsuccessful treatments for depression. Read More
Health Canada will now allow physicians to request restricted psychedelic drugs for patients as part of their psychotherapy through its Special Access Program. Read More
The study followed more than 8,000 people around the world, half of whom were microdosing with psychedelics like magic mushrooms. Read More
The field of psychedelic research for mental health is attracting growing interest from the scientific and medical communities. Read More
The stress of COVID-19 may be contributing to a boom in psychedelic consumption because of the mental health crisis the pandemic has created. Read More
A man died at the porn actor's home in Spain last year after inhaling 5-MeO-DMT, a hallucinatory drug made from toad venom, police say. Read More
RSS Error: A feed could not be found at `https://psychedelicspotlight.com/feed/`; the status code is `200` and content-type is `text/html; charset=UTF-8`
Growing interest in psychedelics has spurred new research decades after hallucinogenics were tested in Saskatchewan in the 1950s. And an unassuming common fish is proving a useful test subject. Read More
It may have ‘worked’ for Winston Churchill. That doesn’t mean it will work for you. Read More
Microdosing involves taking a low dose of a psychedelic drug to enhance performance, or reduce symptoms of stress and anxiety. Here’s what our research shows. Read More
Psychedelics use is on the rise and it’s partly due to a wellbeing rebrand. Read More
In a new research study, more than 900 people from around the world explain the challenges and benefits of microdosing LSD and psilocybin-containing mushrooms. Read More
According to new research, individuals who take small regular doses of psychedelics such as LSD and psilocybin mushrooms score higher on mental health, well-being and creativity. Read More
Enveric Biosciences announced two new patents from the USPTO for its EVM301 and EVM201 series, boosting its total patents to 11 for EVM301. These patents safeguard groundbreaking psilocybin derivatives and… Read More
After years of regulatory hurdles, MAPS has secured FDA clearance to study cannabis for PTSD in a real-world context. This groundbreaking trial focuses on veterans and aims to provide high-quality… Read More
Jill Sitnick’s journey with MDMA-assisted therapy took her from the depths of PTSD to a place of healing and advocacy. In this powerful account, she shares how the therapy helped… Read More
In their Q3 2024 financial updates, atai Life Sciences and Enveric Biosciences demonstrate fiscal discipline and innovation. atai maintains funding into 2026 with a promising psychedelic therapy pipeline, while Enveric… Read More
In a groundbreaking collaboration, Enveric Biosciences has signed a licensing agreement with MycoMedica Life Sciences, granting exclusive rights to develop and commercialize its psilocin-based drug candidate, EB-002. This deal, potentially… Read More
Enveric Biosciences has expanded its intellectual property portfolio with five new U.S. patents for compounds in its EVM301 portfolio, positioning the company as a leader in innovative treatments for neuropsychiatric… Read More
This online survey (n=6,193; 2,488 microdosers) examines differences between exclusive microdosers and those who use both micro and macrodoses of psychedelics. The study finds exclusive microdosers were typically older, more… Read More
This randomised feasibility study (n=37) evaluates psilocybin-assisted (microdoses x 6) frontal-midline theta neurofeedback (NF) to improve executive functions (EFs) in participants with psychiatric disorders. Despite no significant improvements in tasks-based… Read More
This re-analysis of an RCT (n=80) finds no effect of LSD microdosing (10µg, x14) on creativity in healthy adult males. Participants received either LSD or placebo every third day for… Read More
This double-blind, randomized, placebo-controlled study (n=39) examines the effects of a single low dose of LSD (26µg) on event-related potentials during an emotional face oddball task. It finds that LSD… Read More
This placebo-controlled study (n=53) investigates the effects of repeated low doses of LSD (15μg; 4x) on arousal, attention, and memory. LSD produces stimulatory effects, reducing EEG delta, theta, and alpha… Read More
This pre-print (n=13) investigates the subjective experiences of individuals engaging in psilocybin microdosing in their daily lives. Combining momentary ecological assessments and retrospective interviews, participants reported varied effects, including loosening… Read More
MasterChef Canada winner Eric Chong is one of the visionaries behind a new restaurant in Toronto, which aims to bring a unique Asian-fusion dining experience... The post MasterChef Canada winner… Read More
The Chair of the TTC says there’s an opening date in sight for The Eglinton Crosstown, but it isn’t until summer 2025. According to multiple... The post TTC chair hints… Read More
Ontarians are opting for low to no-alcohol options when it comes to consumption nowadays, LCBO says, and a Toronto health expert is offering insight into... The post LCBO reports surge… Read More
Some Torontonians have mixed feelings about the Toronto Transit Commission’s (TTC) decision to deploy plainclothes fare inspectors in order to crack down on fare evasion. ... The post ‘A mistake that… Read More
The holiday break is soon approaching but it can’t come fast enough for some GO Train riders who are voicing their frustrations with how fellow... The post ‘People have forgotten… Read More
The Toronto Tempo is Canada’s first WNBA team, but some Torontonians think the name is not hitting the mark. The announcement came on Thursday morning,... The post ‘Gotta be Tempo-rary,’… Read More
